Get started
Author

Nora Möhn

Observed names: Möhn, Nora, N. Möhn
Observed institutions: Carl von Ossietzky Universität Oldenburg, University of Bonn, University of Cologne, Universität Ulm, University of Münster, University Hospital Bonn, Medizinische Hochschule Hannover, University Hospital Münster, Hospital Clínic de Barcelona, German Center for Infection Research, University Hospital Cologne, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Neurology, Inc, Institut für Klinische Neuroimmunologie, Heinrich Heine University Düsseldorf, University of Göttingen, Ludwig-Maximilians-Universität München, RWTH Aachen University
ORCID: 0000-0002-9102-124X
Observed ORCID: 0000-0002-9102-124X
OpenAlex ID: A5007665367
Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients
2018 · Stefan Gingele, Thais Langer Jacobus, et al. · Cells · 135
PDF
Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy—Review of the Literature and Future Outlook
2019 · Nora Möhn, Gernot Beutel, et al. · Journal of Clinical Medicine · 130
PDF
Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease
2021 · Carles Gaig, Yaroslau Compta, et al. · Neurology · 120
PDF
Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders
2023 · Franz Felix Konen, Nora Möhn, et al. · Autoimmunity Reviews · 80
Leptomeningeal Metastasis: The Role of Cerebrospinal Fluid Diagnostics
2019 · Lena Bönig, Nora Möhn, et al. · Frontiers in Neurology · 71
PDF
Interleukin 17, Produced by γδ T Cells, Contributes to Hepatic Inflammation in a Mouse Model of Biliary Atresia and Is Increased in Livers of Patients
2015 · Christian Klemann, Arne Schröder, et al. · Gastroenterology · 71
PDF
Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published Cases
2020 · Nora Möhn, Franz F. Konen, et al. · Journal of Clinical Medicine · 61
PDF
Extracorporeal cytokine removal in severe CAR-T cell associated cytokine release syndrome
2020 · Klaus Stahl, Bernhard M.W. Schmidt, et al. · Journal of Critical Care · 43
Allogeneic BK Virus-Specific T-Cell Treatment in 2 Patients With Progressive Multifocal Leukoencephalopathy
2021 · Franziska Hopfner, Nora Möhn, et al. · Neurology Neuroimmunology & Neuroinflammation · 41
PDF
Intrathecal Antibody Production Against Epstein-Barr, Herpes Simplex, and Other Neurotropic Viruses in Autoimmune Encephalitis
2021 · Philipp Schwenkenbecher, Thomas Skripuletz, et al. · Neurology Neuroimmunology & Neuroinflammation · 37
PDF
Directly Isolated Allogeneic Virus–Specific T Cells in Progressive Multifocal Leukoencephalopathy
2024 · Nora Möhn, Lea Grote-Levi, et al. · JAMA Neurology · 36
Neurological management and work-up of neurotoxicity associated with CAR T cell therapy
2022 · Nora Möhn, Viktoria Bonda, et al. · Neurological Research and Practice · 36
PDF
18F-FDG PET/CT of off-target lymphoid organs in CD19-targeting chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma
2020 · Thorsten Derlin, Christian Schultze-Florey, et al. · Annals of Nuclear Medicine · 36
PDF
Alemtuzumab therapy changes immunoglobulin levels in peripheral blood and CSF
2019 · Nora Möhn, Steffen Pfeuffer, et al. · Neurology Neuroimmunology & Neuroinflammation · 34
PDF
The Influence of Renal Function Impairment on Kappa Free Light Chains in Cerebrospinal Fluid
2021 · Franz F Konen, Philipp Schwenkenbecher, et al. · Journal of Central Nervous System Disease · 25
PDF
Cerebrospinal Fluid Parameters in Antisense Oligonucleotide-Treated Adult 5q-Spinal Muscular Atrophy Patients
2021 · Lars Hendrik Müschen, Alma Osmanovic, et al. · Brain Sciences · 24
PDF
Acute progressive neuropathy–myositis–myasthenia-like syndrome associated with immune-checkpoint inhibitor therapy in patients with metastatic melanoma
2019 · Nora Möhn, Kurt-Wolfram Sühs, et al. · Melanoma Research · 24
Monocyte chemoattractant protein 1 as a potential biomarker for immune checkpoint inhibitor‐associated neurotoxicity
2023 · Nora Möhn, Susann Mahjoub, et al. · Cancer Medicine · 23
PDF
Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients—Lessons Learned From SARS and MERS
2020 · Nora Möhn, Refik Pul, et al. · Frontiers in Immunology · 23
PDF
Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse
2020 · Nora Möhn, Firas Saker, et al. · Journal of Neurology · 21
PDF
Therapy with cladribine is efficient and safe in patients previously treated with natalizumab
2019 · Nora Möhn, Thomas Skripuletz, et al. · Therapeutic Advances in Neurological Disorders · 21
PDF
Innovative therapeutic concepts of progressive multifocal leukoencephalopathy
2022 · Nora Möhn, Lea Grote-Levi, et al. · Journal of Neurology · 20
PDF
PD-1-inhibitor pembrolizumab for treatment of progressive multifocal leukoencephalopathy
2021 · Nora Möhn, Mike P. Wattjes, et al. · Therapeutic Advances in Neurological Disorders · 18
The relevance of NMDA receptor antibody-specific index for diagnosis and prognosis in patients with anti-NMDA receptor encephalitis
2023 · Martin W. Hümmert, Konstantin F. Jendretzky, et al. · Scientific Reports · 15
PDF
IgG4-related hypertrophic pachymeningitis with tumor-like intracranial and intracerebral lesions
2022 · Majid Esmaeilzadeh, Mete Dadak, et al. · Acta Neurochirurgica · 13
PDF
Works count: 95
Citation count: 1,355
H-index: 21
I10-index: 31
Year
Topic
Type